EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy
- PMID: 25853421
- PMCID: PMC4390304
- DOI: 10.1371/journal.pone.0119605
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy
Abstract
Epstein-Barr virus (EBV) is a non-heritable factor that associates with multiple sclerosis (MS). However its causal relationship with the disease is still unclear. The virus establishes a complex co-existence with the host that includes regulatory influences on gene expression. Hence, if EBV contributes to the pathogenesis of MS it may do so by interacting with disease predisposing genes. To verify this hypothesis we evaluated EBV nuclear antigen 2 (EBNA2, a protein that recent works by our and other groups have implicated in disease development) binding inside MS associated genomic intervals. We found that EBNA2 binding occurs within MS susceptibility sites more than expected by chance (factor of observed vs expected overlap [O/E] = 5.392-fold, p < 2.0e-05). This remains significant after controlling for multiple genomic confounders. We then asked whether this observation is significant per se or should also be viewed in the context of other disease relevant gene-environment interactions, such as those attributable to vitamin D. We therefore verified the overlap between EBNA2 genomic occupancy and vitamin D receptor (VDR) binding sites. EBNA2 shows a striking overlap with VDR binding sites (O/E = 96.16-fold, p < 2.0e-05), even after controlling for the chromatin accessibility state of shared regions (p <0.001). Furthermore, MS susceptibility regions are preferentially targeted by both EBNA2 and VDR than by EBNA2 alone (enrichment difference = 1.722-fold, p = 0.0267). Taken together, these findings demonstrate that EBV participates in the gene-environment interactions that predispose to MS.
Conflict of interest statement
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4390304/bin/pone.0119605.g001.gif)
Similar articles
-
The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.EBioMedicine. 2021 Sep;71:103572. doi: 10.1016/j.ebiom.2021.103572. Epub 2021 Sep 3. EBioMedicine. 2021. PMID: 34488019 Free PMC article.
-
EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis.J Neuroimmunol. 2020 Feb 15;339:577116. doi: 10.1016/j.jneuroim.2019.577116. Epub 2019 Nov 20. J Neuroimmunol. 2020. PMID: 31805475 Review.
-
Genomic Effects of the Vitamin D Receptor: Potentially the Link between Vitamin D, Immune Cells, and Multiple Sclerosis.Front Immunol. 2018 Mar 12;9:477. doi: 10.3389/fimmu.2018.00477. eCollection 2018. Front Immunol. 2018. PMID: 29593729 Free PMC article. Review.
-
Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.J Virol. 2015 Dec 30;90(6):2906-19. doi: 10.1128/JVI.02737-15. J Virol. 2015. PMID: 26719268 Free PMC article.
-
Vitamin D receptor binding, chromatin states and association with multiple sclerosis.Hum Mol Genet. 2012 Aug 15;21(16):3575-86. doi: 10.1093/hmg/dds189. Epub 2012 May 16. Hum Mol Genet. 2012. PMID: 22595971 Free PMC article.
Cited by
-
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?Int J Mol Sci. 2024 Apr 22;25(8):4556. doi: 10.3390/ijms25084556. Int J Mol Sci. 2024. PMID: 38674141 Free PMC article.
-
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome.BMC Genomics. 2024 Mar 12;25(1):273. doi: 10.1186/s12864-024-10183-8. BMC Genomics. 2024. PMID: 38475709 Free PMC article.
-
Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis.J Neurovirol. 2024 Feb;30(1):22-38. doi: 10.1007/s13365-023-01190-8. Epub 2024 Jan 8. J Neurovirol. 2024. PMID: 38189894 Review.
-
Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection.Front Immunol. 2023 Jul 24;14:1212676. doi: 10.3389/fimmu.2023.1212676. eCollection 2023. Front Immunol. 2023. PMID: 37554326 Free PMC article. Review.
-
The interaction between Epstein-Barr virus and multiple sclerosis genetic risk loci: insights into disease pathogenesis and therapeutic opportunities.Clin Transl Immunology. 2023 Jun 17;12(6):e1454. doi: 10.1002/cti2.1454. eCollection 2023. Clin Transl Immunology. 2023. PMID: 37337612 Free PMC article. Review.
References
-
- Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007; 6: 773–781. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical